Trial intelligence / Profile preview

Exploratory Study of Kamishoyosan (TJ-24) for Menopausal Symptoms

jRCT1080223160Phase 4Completed

Sponsor
Tsumura & Co.
Start
Apr 2016
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised, double-blind trial in menopause comparing Kamishoyosan (TJ-24) with Placebo (2 arms). Primary endpoint: Change in excitability and irritability score (NR group). Started Apr 2016; status: completed.

02

Drugs

gamisoyosan
03

Conditions

menopause

Beyond the preview

Go deeper on jRCT1080223160.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on jRCT1080223160.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call